AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Company Reports - CBNB)
Novo Nordisk A/S announced its financial statement for 2006. During 2006: Sales grew by 15% driven by modern insulins; robust sales performance led to operating profit growth of 13%; reported sales increased by 15%; sales of modern insulins (insulin analogs) increased by 48%; sales of NovoSeven increased …